Cargando…

CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia

Alzheimer's disease (AD) is characterized by a sequential progression of amyloid plaques (A), neurofibrillary tangles (T) and neurodegeneration (N), constituting ATN pathology. While microglia are considered key contributors to AD pathogenesis, their contribution in the combined presence of ATN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodder, Chritica, Scheyltjens, Isabelle, Stancu, Ilie Cosmin, Botella Lucena, Pablo, Gutiérrez de Ravé, Manuel, Vanherle, Sarah, Vanmierlo, Tim, Cremers, Niels, Vanrusselt, Hannah, Brône, Bert, Hanseeuw, Bernard, Octave, Jean-Noël, Bottelbergs, Astrid, Movahedi, Kiavash, Dewachter, Ilse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188790/ https://www.ncbi.nlm.nih.gov/pubmed/34103079 http://dx.doi.org/10.1186/s40478-021-01204-8

Ejemplares similares

The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
por: Stancu, Ilie Cosmin, et al.
Publicado: (2022)

Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
por: Stancu, Ilie-Cosmin, et al.
Publicado: (2019)

Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention
por: Botella Lucena, Pablo, et al.
Publicado: (2022)

Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism
por: Stancu, Ilie-Cosmin, et al.
Publicado: (2014)

Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
por: Vasconcelos, Bruno, et al.
Publicado: (2016)

Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo
por: Wang, Peng, et al.
Publicado: (2017)

Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease
por: Couturier, Julien, et al.
Publicado: (2016)

Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
por: Pombo Antunes, Ana Rita, et al.
Publicado: (2020)

Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice
por: Stancu, Ilie-Cosmin, et al.
Publicado: (2015)

Sex-regulated gene dosage effect of PPARα on synaptic plasticity
por: Pierrot, Nathalie, et al.
Publicado: (2019)

CSF metabolites associated with biomarkers of Alzheimer’s disease pathology
por: Dong, Ruocheng, et al.
Publicado: (2023)

Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease
por: Gagliardi, Geoffroy, et al.
Publicado: (2021)

M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
por: Kubota, Yoshiaki, et al.
Publicado: (2009)

CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade
por: Yang, Xianfeng, et al.
Publicado: (2012)

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
por: del Campo, Marta, et al.
Publicado: (2018)

Attenuated CSF‐1R signalling drives cerebrovascular pathology
por: Delaney, Conor, et al.
Publicado: (2020)

Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons
por: Andries, Lien, et al.
Publicado: (2023)

What is the evidence that tau pathology spreads through prion-like propagation?
por: Mudher, Amrit, et al.
Publicado: (2017)

Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD?
por: Boesenberg-Grosse, Constanze, et al.
Publicado: (2006)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology
por: Huang, Yangping, et al.
Publicado: (2020)

Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study
por: Vromen, Eleonora M, et al.
Publicado: (2022)

Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha
por: De Vlaminck, Karen, et al.
Publicado: (2021)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
por: Wang, Qing, et al.
Publicado: (2018)

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
por: Horie, Kanta, et al.
Publicado: (2022)

Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase
por: Maurin, Hervé, et al.
Publicado: (2013)

Odorant receptors can mediate axonal identity and gene choice via cAMP-independent mechanisms
por: Movahedi, Kiavash, et al.
Publicado: (2016)

Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Aβ Oligomers in Cells
por: Decock, Marie, et al.
Publicado: (2016)

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment
por: Radanovic, Márcia, et al.
Publicado: (2017)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond
por: Dayon, Loïc, et al.
Publicado: (2017)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
por: Magliozzi, Roberta, et al.
Publicado: (2021)

Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice
por: Rat, Dorothea, et al.
Publicado: (2011)

CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles
por: Kaeser, Stephan A., et al.
Publicado: (2021)

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
por: Jiang, Richeng, et al.
Publicado: (2022)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives
por: Duerinck, Johnny, et al.
Publicado: (2023)

Pathologic Response After Weekly Paclitaxel versus Docetaxel in Operable Breast Cancer
por: Bacinschi, Xenia Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pibkq7v7i42u24u69gstp859nc